|

Control Clinical Trials

5 actively recruiting trials

Pipeline

Phase 2: 2Phase 3: 3

Top Sponsors

Umeå University1
Suzhou Immunofoco Biotechnology Co., Ltd1
Gruppo Oncologico del Nord-Ovest1
First Affiliated Hospital of Zhejiang University1
Beni-Suef University1

Indications

Cancer4
Liver Disease1
Osteoarthritis, Knee1
Locally Advanced Rectal Cancer (LARC)1
Arthritis1

Other5 trials

A Phase III Randomized Study in CLDN18.2-positive Unresectable Locally Advanced Gastric Cancer Patients

Phase 3

Adjuvant TRastuzumab Deruxtecan for HER2-positive Gastroesophageal Cancer With Persistence of miNImal Residual Disease

Phase 2

BreCLIM-2 - A RCT Investigating Local Treatment for Breast Cancer Liver Metastases

Phase 3

Probiotic Supplements in Osteoarthritis

Phase 3

SCRT Combined With Chemotherapy and Iparomlimab and Tuvonralimab in MSS or pMMR Patients With Locally Advanced Rectal Cancer

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.